Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical ...

Analyst Marie Thibault of BTIG reiterated a Buy rating on Establishment Labs Holdings (ESTA – Research Report), retaining the price ...

People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...

The poisonous flower yellow oleander is showing up in diet supplements. There are now warnings for 22 dietary supplements ...

U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...

Daratumumab plus VRd is a more effective frontline treatment option for patients who cannot undergo immediate transplant, ...

Certain lots of Answers dog food and Darwin's Natural Pet Products, which includes dog and cat food, have been recalled after ...

The FDA claimed these clinics were plying patients with an illegal drug derived from their stem cells. A federal court agrees ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

The panel agreed with the FDA that the treatment in which a patient's tissue is processed doesn't fall under the same ...

The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...

Dupixent may help some people with inadequately controlled COPD who have a type of lung inflammation that worsens symptoms.